Fundz

Savara Inc reported raising $26.8 Million in an initial SEC Form D filing, from an offering of $75 Million

PUBLIC · SVRAJan 02, 2020$26.8M of $75M raised

Amount Raised

$26.8 Million

$26.8 Million sold, per SEC Form D (first sale Jan 2, 2020)

Round Type

Venture

AustinBiotechnologyHealthcareHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Quick answer

Savara Inc raised $26.8 Million in a funding round, dated January 2, 2020. Savara Inc is based in Austin, Texas, United States.

How much did Savara Inc raise?
Savara Inc raised $26.8 Million in a funding round on January 2, 2020.
What does Savara Inc do?
Savara Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with rare respiratory diseases.
Where is Savara Inc based and how big is it?
Savara Inc is based in Austin, Texas, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Savara Inc that raised within 45 days of this round, from Fundz verified event records.

  • VistaGen raised $2.8M (Seed) on January 31, 2020.
  • Immuneering raised $20M on January 27, 2020.
  • Damora Therapeutics, Inc. raised $79M on January 16, 2020.
  • Zevra Therapeutics, Inc. raised $3M (Seed) on January 13, 2020.
  • Verastem Oncology raised $4.8M (Seed) on January 7, 2020.
  • Amylyx Pharmaceuticals raised $937K (Seed) on December 31, 2019.

Who to call at Savara Inc, and when

A new round usually means Savara Inc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Savara Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Savara Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Savara Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Savara Inc

Location

6836 Bee Cave Road

Austin, Texas, United States

About

Savara Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with rare respiratory diseases. The company’s primary business activities involve the research, development, and commercialization of inhaled medications aimed at improving the lives of patients with serious chronic conditions. Key products in their pipeline include specialized treatments designed for individuals suffering from lung diseases. Operating primarily out of Langhorne, Pennsylvania, Savara maintains a commitment to scientific excellence and aims to deliver groundbreaking therapies. Recent developments include advancements in clinical trials that underline the company's strategic focus on addressing unmet medical needs in the respiratory market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Savara Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Savara Inc's next move

See what Strategic adds

Savara Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.